Published in Vaccine Weekly, June 7th, 2006
The international award was based on Chlorogen's efforts to raise venture capital to produce therapeutic proteins in tobacco plants for the treatment of certain ovarian and other reproductive cancers and the company's success in advancing its technology beyond the start-up stage and into product development.
Chlorogen has patented a process called chloroplast transformation technology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly